| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/05/2002 | US20020123107 Nucleotide sequences coding transport protein for use in the diagnosis and treatment of atherosclerosis and nervous system disorders |
| 09/05/2002 | US20020123106 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorders |
| 09/05/2002 | US20020123104 Human slit polypeptide and polynucleotides encoding same |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123101 Process for producing peptides by using in vitro transcription/translation system |
| 09/05/2002 | US20020123100 Transformation of cells with heterologous nucleotide sequences; obtain expression vector, insert heterologous nucleotide sequence, transform cell, express heterologous nucleotide sequences, recover proteins |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123098 55063, a novel human NMDA family member and uses thereof |
| 09/05/2002 | US20020123097 Nucleotide sequences coding polypeptides for use in diagnosis and treatment of liver disorders |
| 09/05/2002 | US20020123096 Dopamine receptors and genes |
| 09/05/2002 | US20020123095 Estrogen receptor alpha variants and methods of detection thereof |
| 09/05/2002 | US20020123094 57250, a novel human sugar transporter family member and uses thereof |
| 09/05/2002 | US20020123093 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 09/05/2002 | US20020123092 Regulatory elements from RP1 gene and uses thereof |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123082 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 09/05/2002 | US20020123076 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 09/05/2002 | US20020123075 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity |
| 09/05/2002 | US20020123073 Multi-channel bio-separation cartridge |
| 09/05/2002 | US20020123067 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 09/05/2002 | US20020123065 Solid support for clones; for use ias tool in the treatment of genetic diorders |
| 09/05/2002 | US20020123064 Hybridization reaction method and hybridization device |
| 09/05/2002 | US20020123062 Detecting preefrential nucleotide sequences in sample; obtain nucleotide sequences, incubate with primer, amplify in cycles, incubate with probe, detect signal |
| 09/05/2002 | US20020123061 Multiple use non-species specific genetic material collection and storage kit |
| 09/05/2002 | US20020123060 Detection of non-viral organisms with SRP RNA |
| 09/05/2002 | US20020123057 Screening for nucleotide sequence which code for prefrential antibodies; obtain cells, transform with expression vector coding antibody, express vector, recover antibody and nucleotide sequences expressing antibody |
| 09/05/2002 | US20020123054 Human angiopoietin |
| 09/05/2002 | US20020123053 Methods for isolating centromere DNA |
| 09/05/2002 | US20020123051 Tumor therapy; obtain tissue, incubate with antitumor agents, fix tissue, isolate nucleotide sequences, amplify and monitor gene expreesion in sample |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123045 Plant transformation process with selection and early identification of germline events |
| 09/05/2002 | US20020123044 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 09/05/2002 | US20020123043 Detecting ligand for preferential receptor; provide a substrate bound receptor, expose to sample, detect bound ligand by spectrum analysis |
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020123041 Method for treatment of canine distemper |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020123038 Nucleotide sequences for use in the treatment of and prevention of viral infections |
| 09/05/2002 | US20020123037 Selection Procedure Using Prodrug/Enzyme System |
| 09/05/2002 | US20020123034 Detecting preferential genetic disorders; obtain cells, transform with vector, recover clones, monitor clone for preferential gene expression, propagate clone expressing preferential genes, monitor killing genes |
| 09/05/2002 | US20020122917 For use in gene sequencing, monitoring gene expression, gene mapping, bacterial identification, drug discovery, and combinatorial chemistry |
| 09/05/2002 | US20020122819 Preparing invaginated liposomes by heating 1,2-bis(oleoyloxy) -3-(trimethylammonio)- propane and cholesterol or a derivative; sonicating; and extruding lipid components sequentially through filters of decreasing pore size |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | US20020122789 Modified by an insertion nucleic acid coding for a polypeptide sequence to be expressed in said muscle cells, are used to obtain a drug for treating muscle cell diseases or diseases |
| 09/05/2002 | US20020122788 Long-term expression of gene products by transforming muscle cells |
| 09/05/2002 | DE10157799A1 Gene transfer to animal cells, useful in vitro or for gene therapy, using vector DNA treated sequentially in water with oppositely charged polyelectrolytes |
| 09/05/2002 | DE10109996A1 Verfahren zur Veränderung des Genoms von gram-positiven Bakterien mit einem neuen konditional negativ dominanten Markergen A method for modifying the genome of Gram-positive bacteria with a new conditionally negative dominant marker gene |
| 09/05/2002 | DE10109780A1 Episomale Vektoren enthaltend Matrix-Anheftungsregionen zur zellspezifischen Genexpression Episomal vectors containing matrix attachment regions of cell-specific gene expression |
| 09/05/2002 | DE10107677A1 Verfahren zur Erzeugung und Transformation von Mitochondrien-Konglomeraten A process for the production and transformation of mitochondria conglomerates |
| 09/05/2002 | DE10107676A1 Verfahren zur Erhöhung des Ölgehalts in transgenen Pflanzen und Pflanzensamen A method for increasing the oil content in transgenic plants and plant seeds |
| 09/05/2002 | DE10106835A1 Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen Signal transduction 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences |
| 09/05/2002 | DE10106718A1 Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters Yeast strain of Saccharomyces cerevisiae with functional expression of Glut-transporter |
| 09/05/2002 | CA2374420A1 Method for producing proteins |
| 09/04/2002 | EP1237114A2 Probe designing method and information processing apparatus |
| 09/04/2002 | EP1236806A2 Oligonucleotide and method for detecting verotoxin |
| 09/04/2002 | EP1236804A1 A method for determination of a nucleic acid using a control |
| 09/04/2002 | EP1236801A2 Method of agrobacterium mediated plant transformation through treatment of germinating seeds |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1236798A2 Gene library and method for its production |
| 09/04/2002 | EP1236796A1 Novel enone reductases isolated from Kluyveromyces lactis, methods for producing same, and methods for selectively reducing a carbon-carbon double bond of an Alpha, Beta-unsaturated ketone using the reductases |
| 09/04/2002 | EP1236739A2 59914 and 59921 Choline transporters and uses therefore |
| 09/04/2002 | EP1236738A1 Internal standard for electrophoretic and chromatographic separation process |
| 09/04/2002 | EP1236729A1 Clavulanic acid aldehyde, beta-lactamase inhibitor |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236173A2 Methods and devices for identifying patterns in biological systems |
| 09/04/2002 | EP1236045A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 09/04/2002 | EP1236044A2 Diagnosing and treating arthritic disorders |
| 09/04/2002 | EP1236034A1 Biosensing using surface plasmon resonance |
| 09/04/2002 | EP1235939A2 Normalization controls and duplex probes for quantitative hybridization reactions |
| 09/04/2002 | EP1235938A2 Fluorescent quenching detection reagents and methods |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235935A1 Targeted methods of drug screening using co-culture methods |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235930A2 Electrophoretic analysis of target molecules using adapter molecules |
| 09/04/2002 | EP1235929A2 Replica amplification of nucleic acid arrays |
| 09/04/2002 | EP1235926A2 Acyl glucosaminyl inositol amidase family and methods of use |
| 09/04/2002 | EP1235924A1 Antisense modulation of rank expression |
| 09/04/2002 | EP1235922A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 09/04/2002 | EP1235921A2 Sugarbeet regeneration and transformation |
| 09/04/2002 | EP1235920A2 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 09/04/2002 | EP1235919A1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 09/04/2002 | EP1235918A2 Methods for altering the expression of hyphal-specific genes |
| 09/04/2002 | EP1235917A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
| 09/04/2002 | EP1235916A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 09/04/2002 | EP1235915A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 09/04/2002 | EP1235914A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 09/04/2002 | EP1235913A2 Sphingosine kinase, cloning, expression and methods of use |
| 09/04/2002 | EP1235912A2 Tumour-specific vector for gene therapy |
| 09/04/2002 | EP1235911A2 Genes involved in cyclododecanone degradation pathway |
| 09/04/2002 | EP1235910A1 Plant virus particles with exogenous internal eitopes |
| 09/04/2002 | EP1235909A1 Human adam-ts proteases and polynucleotides encoding the same |
| 09/04/2002 | EP1235908A2 Polypeptides and polynucleotides encoding same |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235906A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 09/04/2002 | EP1235905A2 Device for extraction of nucleic acids |
| 09/04/2002 | EP1235903A2 Metabollically engineered cells overexpressing pyruvate carboxylase or pyruvate phosphoenolpyruvate carbokylase, and methods to produce and use such cells |